FDA.reportPublic FDA data

Latisse 0.3 MG/ML Topical Solution

RxCUI
1041497
RxNorm name
Latisse 0.3 MG/ML Topical Solution
Display name
Latisse 0.3 MG/ML Topical Solution
Full name
Latisse 0.3 MG/ML Topical Solution
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:53

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LATISSEBIMATOPROSTAllergan, Inc.34f83d9d-2c64-463e-8a90-9a460fedfead2024-07-01Warnings, Adverse reactionsExact identifier
rxcui: 1041497

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
34f83d9d-2c64-463e-8a90-9a460fedfeadLatisse 0.3 MG/ML Topical SolutionSY25These highlights do not include all the information needed to use LATISSE safely and effectively. See full prescribing information for LATISSE. LATISSE ® (bimatoprost ophthalmic solution) 0.03% , for topical ophthalmic use Initial U.S. Approval: 200120240701
34f83d9d-2c64-463e-8a90-9a460fedfeadbimatoprost 0.3 MG/ML Topical Solution [Latisse]SBD25These highlights do not include all the information needed to use LATISSE safely and effectively. See full prescribing information for LATISSE. LATISSE ® (bimatoprost ophthalmic solution) 0.03% , for topical ophthalmic use Initial U.S. Approval: 200120240701
34f83d9d-2c64-463e-8a90-9a460fedfeadLatisse 0.03 % Eyelash Topical SolutionPSN25These highlights do not include all the information needed to use LATISSE safely and effectively. See full prescribing information for LATISSE. LATISSE ® (bimatoprost ophthalmic solution) 0.03% , for topical ophthalmic use Initial U.S. Approval: 200120240701
34f83d9d-2c64-463e-8a90-9a460fedfeadLatisse 0.03 % Eyelash Topical SolutionSY25These highlights do not include all the information needed to use LATISSE safely and effectively. See full prescribing information for LATISSE. LATISSE ® (bimatoprost ophthalmic solution) 0.03% , for topical ophthalmic use Initial U.S. Approval: 200120240701